LEADER 03446nam  22007454a 450 
001 9910698434403321
005 20200520144314.0
010   $a9786610518548
010   $a9781040174166
010   $a1040174167
010   $a9780429163203
010   $a0429163207
010   $a9781280518546
010   $a1280518545
010   $a9780849362927
010   $a084936292X
024 7 $a10.1201/b14187 
035   $a(CKB)1000000000346208
035   $a(EBL)264678
035   $a(OCoLC)475988652
035   $a(SSID)ssj0000266341
035   $a(PQKBManifestationID)11239383
035   $a(PQKBTitleCode)TC0000266341
035   $a(PQKBWorkID)10305552
035   $a(PQKB)10318976
035   $a(MiAaPQ)EBC1404996
035   $a(MiAaPQ)EBC264678
035   $a(OCoLC)72478213
035   $a(Au-PeEL)EBL264678
035   $a(OCoLC)814457994
035   $a(OCoLC)657324070
035   $a(EXLCZ)991000000000346208
100   $a20050819d2006      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aUterine cancer /$fedited by David M. Luesley, Frank G. Lawton, Andrew Berchuck
205   $aRev. Mar. 2009.
210   $aNew York $cTaylor & Francis$d2006
215   $a1 online resource (315 p.)
225 1 $aCDC publication #99-9125
300   $aDescription based upon print version of record.
311 08$a9780824759513 
311 08$a0824759516 
320   $aIncludes bibliographical references and index.
327   $aFront Cover; Preface; Contents; Contributors; 1.  Epidemiology; 2.  Screening in Endometrial Cancer; 3.  Pathology of Endometrial Hyperplasia and Neoplasia; 4.  Pathology of Uterine Sarcoma; 5.  The Molecular Genetics of Endometrial Cancer; 6.  Clinical Presentation and Investigation: The ''One-Stop'' Clinic, Endometrial Sampling, Hysteroscopy, Vaginal Ultrasound; 7.  Imaging Endometrial Cancer; 8.  Surgery for Uterine Cancer; 9.  Risk Factors and the Role of Radiotherapy in the Treatment of Endometrial Cancer; 10.  Chemotherapy for Uterine Cancer
327   $a11.  Minimal Access Surgery in Endometrial Cancer12.  Follow-Up and Detection of Relapsed Disease in Uterine Cancer; 13.  The Role of Surgery in Advanced and Relapsed Disease; 14.  Endometrial Carcinoma and Hormone Replacement Therapy; 15.  Future Developments in Radiation Therapy for Endometrial Carcinoma; 16.  Future Directions: Chemotherapy and Novel Agents for Uterine Cancer; 17.  Combined Therapy in Uterine Cancer: Future Directi
330   $aThis authoritative reference compiles the latest studies on the epidemiology, diagnosis, and treatment of uterine cancer and offers an extensive review of the molecular pathogenesis of endometrial and uterine disorders-analyzing patterns of disease presentation as population demographics change and considering the challenges this will place on future healthcare procedures.
410  0$aDHHS publication ;$vno. 99-9125.
606   $aUterus$xCancer
615  0$aUterus$xCancer.
676   $a616.99/466
701   $aLuesley$b David$01351625
701   $aLawton$b Frank G$01351626
701   $aBerchuck$b Andrew$01351627
712 02$aCenters for Disease Control and Prevention (U.S.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910698434403321
996   $aUterine cancer$93124853
997   $aUNINA